Psychedelic Therapy: A Primer for Primary Care Clinicians—Lysergic Acid Diethylamide (LSD).

MLA

Beutler, Bryce D., et al. “Psychedelic Therapy: A Primer for Primary Care Clinicians—Lysergic Acid Diethylamide (LSD).” American Journal of Therapeutics, vol. 31, no. 2, Mar. 2024, pp. e104–11. EBSCOhost, https://doi.org/10.1097/MJT.0000000000001726.

APA

Beutler, B. D., Shinozuka, K., Tabaac, B. J., Arenas, A., Cherian, K., Evans, V. D., Fasano, C., & Muir, O. S. (2024). Psychedelic Therapy: A Primer for Primary Care Clinicians—Lysergic Acid Diethylamide (LSD). American Journal of Therapeutics, 31(2), e104–e111. https://doi.org/10.1097/MJT.0000000000001726

Chicago

Beutler, Bryce D., Kenneth Shinozuka, Burton J. Tabaac, Alejandro Arenas, Kirsten Cherian, Viviana D. Evans, Chelsey Fasano, and Owen S. Muir. 2024. “Psychedelic Therapy: A Primer for Primary Care Clinicians—Lysergic Acid Diethylamide (LSD).” American Journal of Therapeutics 31 (2): e104–11. doi:10.1097/MJT.0000000000001726.